CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
2009 · Cell · 1,704 citations
https://doi.org/10.1016/j.cell.2009.05.045
W
Wendy W. Pang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
75
Papers
7.4K
Citations
16
h-index
19
i10-index
Wendy W. Pang is an academic researcher from United Therapeutics (United States). The author has contributed to research in topics: Acute Myeloid Leukemia Research & Hematopoietic Stem Cell Transplantation & Immune Cell Function and Interaction. The author has an h-index of 16, co-authored 64 publications.
ORCID: 0000-0002-3707-2767Papers by this author
worksHuman bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age
2011 · Proceedings of the National Academy of Sciences · 975 citations
https://doi.org/10.1073/pnas.1116110108
Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes
2013 · Proceedings of the National Academy of Sciences · 281 citations
https://doi.org/10.1073/pnas.1222861110
Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservation
2019 · Nature Communications · 186 citations
https://doi.org/10.1038/s41467-018-08201-x
Sleep disruption impairs haematopoietic stem cell transplantation in mice
2015 · Nature Communications · 49 citations
https://doi.org/10.1038/ncomms9516
Initial results from BEACON, a phase 1b/2a dose escalation study of the anti-c-Kit briquilimab antibody in adults with chronic spontaneous urticaria (CSU)
2025 · Journal of Allergy and Clinical Immunology · 3 citations
https://doi.org/10.1016/j.jaci.2024.12.998
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat